Podcast
June 5, 2023
Tools, knowledge, and recognition to improve vaccination rates and protect residents and staff.
Showing 21 - 30 of 105 results
JAMDA
May 22, 2023
Factors Associated With Benzodiazepine and Antipsychotic Prescribing in Hospice: A Qualitative Study of Hospice Prescribers
Benzodiazepine and antipsychotic medications are common components of the hospice toolkit and are routinely prescribed for behavioral symptom management at end of life. These medications have significant associated risks but, despite their frequent use, little is known about how clinicians weigh prescribin...
JAMDA
May 20, 2023
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease
The use of antipsychotics in persons with Parkinson's disease (PD) is common, although their use may aggravate the symptoms of PD. Clozapine and quetiapine are the only antipsychotics recommended in PD treatment guidelines. Information on factors associated with initiation of antipsychotics is needed....
JAMDA
April 28, 2023
Federal Nursing Home Policies on Antipsychotics had Similar Impacts by Race and Ethnicity for Residents With Dementia
Federal initiatives have been successful in reducing antipsychotic exposure in nursing home residents with dementia. We assessed if these initiatives were implemented equally across racial and ethnic minority groups.
Podcast
April 27, 2023
JAMDA On-The-Go | April 2023 | Insights into Infection Control, Oral Health, Antipsychotic Use, and Virtual Reality for Older Adults
JAMDA
April 20, 2023
Potentially Harmful Medication Prescribing by the Degree of Physician Specialization in Nursing Home Practice: An Observational Study
The use of anticholinergics, antipsychotics, benzodiazepines, and other potentially harmful medications (PHMs) is associated with particularly poor outcomes in nursing home (NH) residents with Alzheimer's disease and related dementias (ADRD). Our objective was to compare PHM prescribing by NH physicia...
Spotlight
March 31, 2023
Optimizing the Use of Gabapentin: A Special Drive to Deprescribe Podcast
Medication optimization is a hot topic in post-acute and long-term care and a focus of AMDA’s very popular Drive to Deprescribe (D2D) initiative. Now practitioners have yet another opportunity to address their deprescribing challenges with a new quarterly D2D podcast. The first program addresses Optimizing...
Podcast
March 30, 2023
AMDA On-The-Go | ASA & Clopidogrel - When is it Too Much of a Good Thing? (D2D Special Edition)
JAMDA
March 21, 2023
Trends in Risk-Adjusted Initiation and Reduction of Opioid Use among Veterans With Dementia in US Department of Veterans Affairs Community Living Centers
Proper initiation and reduction of opioids is important in providing effective and safe pain relief to Veterans with dementia, including in Community Living Centers (CLCs). We examined the trends in aggregated monthly risk-adjusted opioid administration days and dosage over 3 opioid safety regulatory perio...
Press Release
March 15, 2023
